We are live on
!
Find out more
Point72 Asset Management Portfolio holdings
AUM
$78.1B
1-Year Est. Return
55.25%
This Fund
S&P 500
This Quarter
Est. Return
-2.81%
1 Year Est. Return
+55.25%
3 Year Est. Return
+151.79%
5 Year Est. Return
+188.05%
10 Year Est. Return
+800.63%
AUM
$25.2B
AUM Growth
+$145M
(+0.58%)
Cap. Flow
+$1.25B
Cap. Flow
% of AUM
4.95%
Top 10 Holdings %
Top 10 Hldgs %
11.42%
Holding
1,496
New
423
Increased
299
Reduced
316
Closed
358
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$278M |
| 2 |
Analog Devices
ADI
|
+$181M |
| 3 |
Target
TGT
|
+$172M |
| 4 |
Visa
V
|
+$150M |
| 5 |
Broadcom
AVGO
|
+$148M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$454M |
| 2 |
Micron Technology
MU
|
+$168M |
| 3 |
Suncor Energy
SU
|
+$146M |
| 4 |
Cheniere Energy
LNG
|
+$129M |
| 5 |
Amazon
AMZN
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.22% |
| 2 | Technology | 16.94% |
| 3 | Consumer Discretionary | 10.54% |
| 4 | Industrials | 7.2% |
| 5 | Energy | 6.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
Fossil Group
FOSL
$349M
| $1.3M | 0.01% |
+135,100
| New | +$1.53M |
|
|
ICPT
902
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $1.25M | ﹤0.01% |
76,500
-437,700
| -85% | -$6.86M |
|
|
BKI
903
DELISTED
Black Knight, Inc. Common Stock
BKI
| $1.24M | ﹤0.01% |
21,400
+6,500
| +44% | +$428K |
|
904
Coca-Cola Europacific Partners
CCEP
$48B
| $1.24M | ﹤0.01% |
25,500
-566,788
| -96% | -$30.4M |
|
905
Corvus Pharmaceuticals
CRVS
$1.17B
| $1.22M | ﹤0.01% |
745,000
-50,000
| -6% | -$91.5K |
|
|
ADAP
906
DELISTED
Adaptimmune Therapeutics
ADAP
| $1.2M | ﹤0.01% |
582,508
+17,300
| +3% | +$46.7K |
|
|
CLYM
907
Climb Bio
CLYM
$714M
| $1.19M | ﹤0.01% |
+142,333
| New | +$1.33M |
|
|
OPTU
908
Optimum Communications Inc
OPTU
$307M
| $1.19M | ﹤0.01% |
+95,400
| New | +$1.27M |
|
909
Ametek
AME
$58.4B
| $1.19M | ﹤0.01% |
8,900
-144,209
| -94% | -$19.4M |
|
910
Hawaiian Electric Industries
HE
$2.17B
| $1.15M | ﹤0.01% |
+27,100
| New | +$1.13M |
|
911
Arcosa
ACA
$7.14B
| $1.15M | ﹤0.01% |
20,000
| – | – |
|
912
RLI Corp
RLI
$5.77B
| $1.14M | ﹤0.01% |
20,600
-8,800
| -30% | -$464K |
|
913
Gates Industrial Corporation Ltd.
GTES
$7.42B
| $1.13M | ﹤0.01% |
+75,000
| New | +$1.17M |
|
914
CALL
Wayfair
W
$14.2B
| $1.11M | ﹤0.01% |
+10,000
| New | +$1.41M |
|
|
TSE
915
DELISTED
Trinseo
TSE
| $1.1M | ﹤0.01% |
+22,900
| New | +$1.2M |
|
916
CALL
Innoviz Technologies
INVZ
$88.8M
| $1.09M | ﹤0.01% |
301,800
| – | – |
|
917
YPF
YPF
$19.1B
| $1.09M | ﹤0.01% |
225,600
+150,900
| +202% | +$649K |
|
|
PPBT
918
Purple Biotech
PPBT
$1.4M
| $1.07M | ﹤0.01% |
1,357
-39
| -3% | -$25.2K |
|
919
Super Micro Computer
SMCI
$19.6B
| $1.06M | ﹤0.01% |
+279,000
| New | +$1.15M |
|
920
DraftKings
DKNG
$10.8B
| $1.02M | ﹤0.01% |
+52,568
| New | +$1.12M |
|
921
Sabre
SABR
$838M
| $1.02M | ﹤0.01% |
89,500
-1,435,200
| -94% | -$14.1M |
|
922
Teladoc Health
TDOC
$1.26B
| $1.02M | ﹤0.01% |
+14,161
| New | +$1.02M |
|
923
Genius Sports
GENI
$2.23B
| $1.01M | ﹤0.01% |
220,000
-100
| -0% | -$576 |
|
924
Abeona Therapeutics
ABEO
$388M
| $1.01M | ﹤0.01% |
128,000
| – | – |
|
|
CITE
925
DELISTED
Cartica Acquisition Corp Class A Ordinary Shares
CITE
| $1M | ﹤0.01% |
+100,000
| New | +$996K |
|
Similar funds
CBU
BC
Point72 Asset Management's Q1 2022 Portfolio in Review
As of Q1 2022, Point72 Asset Management held 1,496 positions worth $25.2B, up 0.58% from $25B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Point72 Asset Management deployed $1.25B of net new capital in Q1 2022, opening 423 new positions and adding to 299 existing holdings. Its largest new stake was Target: 794,997 shares worth $169M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 23% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Micron Technology, an estimated $168M trimmed.
- Point72 Asset Management's largest Q1 2022 buy was Target: 794,997 shares worth $169M.
- Point72 Asset Management added most to Merck in Q1 2022, an estimated $278M increase.
- Point72 Asset Management's biggest Q1 2022 reduction was Micron Technology, cutting an estimated $168M.
- Point72 Asset Management fully exited iShares Core S&P 500 ETF in Q1 2022, selling an estimated $454M.
- Point72 Asset Management's ten largest holdings make up 11% of its $25.2B portfolio in Q1 2022.
- Point72 Asset Management opened 423 new positions and closed 358 in Q1 2022.
- Point72 Asset Management's portfolio value rose 0.58% quarter-over-quarter to $25.2B.
Based on Point72 Asset Management's 13F filing for Q1 2022, filed 16 May 2022.